Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:04 AM
Study NCT ID:
NCT05764720
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-02-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Sponsor:
Varian, a Siemens Healthineers Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-13
First Submit QC Date:
None
Study First Post Date:
2023-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED